Stock Market News: Zoono Group (ZNO)
Zoono Group (ZNO) continues to soar as it today up another 25% after it announced an exclusive distributorship in Singapore for its technology to combat viruses and bacteria. One of the few winners from the Coronavirus outbreak. The company is awaiting German lab tests on its efficacy in fighting the virus. Since we recommended ZNO as a speculative buy on January 22nd at 61c it is now up around 400%. ZNO is a global biotech company that develops, manufactures and distributes a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions.
Zoono Group (ZNO) continues to soar as it today up another 25% after it announced an exclusive distributorship in Singapore for its technology to combat viruses and bacteria. One of the few winners from the Coronavirus outbreak. The company is awaiting German lab tests on its efficacy in fighting the virus. Since we recommended ZNO as a speculative buy on January 22nd at 61c it is now up around 400%. ZNO is a global biotech company that develops, manufactures and distributes a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions
Zoono Group (ZNO) continues to soar as it today up another 25% after it announced an exclusive distributorship in Singapore for its technology to combat viruses and bacteria. One of the few winners from the Coronavirus outbreak. The company is awaiting German lab tests on its efficacy in fighting the virus. Since we recommended ZNO as a speculative buy on January 22nd at 61c it is now up around 400%. ZNO is a global biotech company that develops, manufactures and distributes a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions.
Zoono Group (ZNO) continues to soar as it today up another 25% after it announced an exclusive distributorship in Singapore for its technology to combat viruses and bacteria. One of the few winners from the Coronavirus outbreak. The company is awaiting German lab tests on its efficacy in fighting the virus. Since we recommended ZNO as a speculative buy on January 22nd at 61c it is now up around 400%. ZNO is a global biotech company that develops, manufactures and distributes a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions